I’ve been studying metabolic disorders for more than a decade, looking very closely at ways that we can bring in laboratory information to gain deeper insight to our patients’ unique needs.
I can say that I’m one of those practitioners who runs both glucose and insulin testing at fasting two-hour intervals, and I have been doing this for more than a decade. The reason I do this is that I gain such valuable insight into understanding how to modify the diet, and insight into [the level of] severity that our patients may be presenting with regard to an insulin-sensitive or insulin resistant syndrome.
The guiding light that comes from the laboratory report helps me set the stage for how I’m going to personalize the program. This information helps me determine if the patient is running toward a hypoglycemic trend, or if we are we potentially dealing with a very severe pre-, pre-, pre-diabetes that needs a more aggressive and assertive therapeutic intervention.
I personally have found that the majority of my patients do not suffer during the testing process. I tell them to bring a book and have something to do because they’re not going to walk around or exercise. They’re going to spend a couple of hours sitting in a lab waiting for that second blood draw to take place. So prepare them, let them know what to expect.
Set them up for success in knowing why it is that you’re gathering that information, and how it will help you make more unique and personalized recommendations.
A 2018 study provides the first published evidence that lead exposure results in DNA damage via oxidative stress and promoter methylation of DNA repair genes in human cell lines. What other emerging research links lead to undesirable health outcomes?Read More
In many countries, mortality due to atherosclerosis has been decreasing over the decades.1 Yet atherosclerosis still correlates with very high health risks, including ischemic stroke, and modifiable lifestyle factors play a huge role.2-3 In the video below, Elizabeth Boham, MD, MS, RD, IFMCP, describes her first steps in working with patients to decrease their cardiometabolic health risks when atherosclerosis is present.Read More
Assessing cardiometabolic risks has evolved over time. Simultaneously, primary care is still the proposed central hub for evaluating cardiometabolic risks and intervening.1-3 In the video below, Shilpa P. Saxena, MD, IFMCP, an IFM educator, explains the shift in her thinking for addressing cardiometabolic risk in her patients since medical school.Read More